Company intelligence / Profile preview

CSPC Zhongnuo Pharmaceutical

Shijiazhuang, Hebei Province, Chinaen.e-cspc.com ↗
Ownership
Private
Development stage
Other
01

Overview

Major supplier of generic antibiotics and APIs in China with a broad portfolio of over forty antibiotic products as well as other small molecules. Part of a leading Chinese pharma group with strong R&D capabilities focused on both generics and innovative drugs.

Therapeutic areas
NeurologyPulmonologyInfectious DiseasesHematologyEndocrinologyOncologyImmunologyCardiovascular
Modalities
Small moleculesiRNAHerbal medicineLiposomal drug formulation
Industry
Biotech
02

Drug pipeline

5 assets

daunorubicin and cytarabine (CSPC Zhongnuo Pharmaceutical)

4

4 more assets in the full pipeline.

Beyond the preview

Go deeper on CSPC Zhongnuo Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CSPC Zhongnuo Pharmaceutical.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call